Analyst Ratings for Caris Life Sciences Inc (CAI)
CAI Rating Summary
CAI Price Target Summary
- Highest: $37.00 (BofA Securities)
- Lowest: $21.00 (Piper Sandler)
- Average: $29.27
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$29.27 (+77.5%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
Rating Score: 6.1 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/1/2026 | Wolfe Research | Mike Polark | New Coverage | Peerperform (N/A) |
N/A (N/A) |
16.72 (16.49) |
-1.38% | Details |
| 4/13/2026 | Jefferies | Tycho Peterson | New Coverage | Buy (N/A) |
28.00 (N/A) |
19.20 (16.49) |
-14.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
